Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study
Intensive Care Medicine · 2026-02 · 52 (2) · 240-251
DOI: 10.1007/s00134-025-08268-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Intensive Care Medicine, online erschienen am 12.01.2026. Verfasst von Matthieu Schmidt und 51 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris, France. matthieu.schmidt@aphp.fr. Hauptthemen laut MEDLINE: Myocarditis, Extracorporeal Membrane Oxygenation, Heart-Assist Devices. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Temporary mechanical circulatory support (t-MCS) is increasingly used in fulminant myocarditis (FM), yet long-term outcomes and risk factors remain poorly defined. METHODS: From the FULLMOON international cohort (419 adults with suspected FM across 36 centers in 15 countries), 295 patients treated with venoarterial extracorporeal membrane oxygenation (V-A ECMO) and/or Impella were analyzed. The primary endpoint was mortality at 1 year, heart transplantation (HTx), or left-ventricular assist device (LVAD). Multivariate Cox regression identified predictors of adverse outcomes. A propensity score-weighted analysis assessed outcomes based on timing of endomyocardial biopsy (EMB): early (≤ 2 days), delayed (> 2 days), or none. RESULTS: The median age was 39 years (IQR 28-60), and 55% were female. Myocarditis was confirmed in 204 (69%) of the patients via histology or cardiac MRI. Histological data were available for 151 (51%) of the cohort. One-year mortality was 36%, while 44% died or had an HTx or LVAD. Predictors of worse outcomes were giant cell myocarditis, older age, cardiac arrest at ECMO initiation, and delayed EMB. Delayed EMB was consistently associated with higher mortality, HTx, or LVAD compared to early (HR = 1.55; 95% CI 1.23-1.96; p < 0.01) or no EMB (HR = 1.59; 95% CI 1.26-2.01; p < 0.01). However, event-free survival did not differ significantly between early EMB and no EMB (HR = 1.03; 95% CI 0.80-1.32; p = 0.85). CONCLUSIONS: Despite a relatively young cohort, FM requiring t-MCS is associated with a high 1-year mortality rate. Timely recognition and early referral to specialized ECMO centers before cardiac arrest are critical.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne Université, INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris, France. matthieu.schmidt@aphp.fr.
- Medical Intensive Care Unit, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. matthieu.schmidt@aphp.fr.
- ICAN Intelligence and Omics, Institute of Cardiometabolism and Nutrition, Pitié-Salpêtrière Hospital, Paris, France.
- Medical Intensive Care Unit, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- ACTION Study Group, Department of Cardiology, Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
- Acute Cardiovascular Care Unit, Cardiology, Hospital Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
ORCID-Profile: Matthieu Schmidt
Zitieren
APA
Schmidt, M., Ponnaiah, M., Huang, F., Montero, S., Raimbault, V., Abrams, D., Lebreton, G., Pellegrino, V., Ihle, J., Bottiroli, M., Persichini, R., Barrionuevo-Sánchez, M. I., Ariza Solé, A., Ng, P. Y., Ching, S. S. W., Ayer, R., Buscher, H., Biendel, C., Delmas, C., …, & FULLMOON Study Group (2026). Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study. Intensive Care Medicine, 52(2), 240-251. https://doi.org/10.1007/s00134-025-08268-3
Vancouver
Schmidt M, Ponnaiah M, Huang F, Montero S, Raimbault V, Abrams D, et al. Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study. Intensive Care Medicine. 2026;52(2):240-251. doi:10.1007/s00134-025-08268-3
BibTeX
@article{Schmidt2026,
author = {Schmidt, Matthieu and Ponnaiah, Maharajah and Huang, Florent and Montero, Santiago and Raimbault, Victor and Abrams, Darryl and Lebreton, Guillaume and Pellegrino, Vincent and Ihle, Joshua and Bottiroli, Maurizio and Persichini, Romain and Barrionuevo-Sánchez, M Isabel and Ariza Solé, Albert and Ng, Pauline Yeung and Ching, Simon Sin Wai and Ayer, Raj and Buscher, Hergen and Biendel, Caroline and Delmas, Clément and Ferreira, Rita and Roncon-Albuquerque, Roberto and Lόpez-Sobrino, Teresa and Bunge, Jeroen J H and Fisser, Christoph and Franchineau, Guillaume and McCanny, Jamie and Ohshimo, Shinichiro and Sionis, Alessandro and Hernández-Pérez, Francisco José and Barge-Caballero, Eduardo and Balik, Martin and Muglia, Henrique and Park, Sunghoon and Donker, Dirk W and Porral, Beatriz and Aïssaoui, Nadia and Mekontso Dessap, Armand and Burgos, Virginia and Lesouhaitier, Mathieu and Fried, Justin and Jung, Jae-Seung and Rosillo, Sandra and Scherrer, Vincent and Nseir, Saad and Winszewski, Hadrien and Jorge-Pérez, Pablo and Kimmoun, Antoine and Diaz, Rodrigo and Hekimian, Guillaume and Ammirati, Enrico and Combes, Alain and FULLMOON Study Group, FULLMOON Study Group},
title = {Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study},
journal = {Intensive Care Medicine},
year = {2026},
volume = {52},
number = {2},
pages = {240--251},
doi = {10.1007/s00134-025-08268-3}
}
EUVIMED